Eurofins Scientific
€74.86Change from previous close: +0.43%Absolute change: +€0.32
Valuation
Data as of October 4, 2026
Valuation multiples
- Market cap
- €12.81B
- Enterprise value
- €16.83B
- P/E (trailing 12 months)
- 26.0
- Forward P/E
- 16.2
- PEG
- 0.94
- Price/book
- 3.59
- Price/sales
- 1.73
- EV/EBITDA
- 10.9
- EV/revenue
- 2.28
Profitability and growth
- Gross margin
- 23.1%
- Operating margin
- 16.2%
- Net margin
- 7.2%
- ROE
- 11.3%
- ROA
- 6.0%
- ROIC
- 8.9%
- Revenue growth (year over year)
- 2.5%
- Earnings growth (year over year)
- 28.4%
Financial health
- Total cash
- €617.8M
- Total debt
- €4.47B
- Debt/equity
- 0.96
- Current ratio
- 1.13
- Quick ratio
- 0.87
- Altman Z-Score
- 2.45
- Piotroski F-Score
- 6.00
Dividends
- Annual dividend per share
- €0.72
- Dividend yield
- 1.0%
- Payout ratio
- 25.0%
- Ex-dividend date
- April 28, 2026
Analysts and estimates
- Average price target
- €72.01
- Median price target
- €72.35
- High price target
- €86.00
- Low price target
- €58.00
- Analysts with a price target
- 14
- Consensus
- Hold
- Forward EPS
- €4.62
- EPS estimate, current year
- €4.09
Shares and trading
- Beta
- 0.85
- Average volume
- 273.04K
- Shares outstanding
- 171.11M
- Float
- 110.07M
- Institutional ownership
- 34.3%
- Insider ownership
- 36.5%